TrialJAMA network open2022

Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial.

Matthew Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.